Manno-epi-cyclophellitols Enable Activity-Based Protein Profiling of Human α-Mannosidases and Discovery of New Golgi Mannosidase II Inhibitors
- 30 June 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 142 (30) , 13021-13029
Abstract
Golgi mannosidase II (GMII) catalyzes the sequential hydrolysis of two mannosyl residues from GlcNAcMan5GlcNAc2 to produce (GlcNAcMan3GlcNAc2), the precursor for all complex N-glycans, including the branched N-glycans associated with cancer. Inhibitors of GMII are potential cancer therapeutics, but their usefulness is limited by off-target effects, which produce α-mannosidosis-like symptoms. Despite many structural and mechanistic studies of GMII, we still lack a potent and selective inhibitor of this enzyme. Here, we synthesized manno-epi-cyclophellitol epoxide and aziridines and demonstrate their covalent modification and time-dependent inhibition of GMII. Application of fluorescent manno-epi-cyclophellitol aziridine derivatives enabled activity-based protein profiling of α-mannosidases from both human cell lysate and mouse tissue extracts. Synthesized probes also facilitated a fluorescence polarization-based screen for dGMII inhibitors. We identified seven previously unknown inhibitors of GMII from a library of over 350 iminosugars and investigated their binding modalities through X-ray crystallography. Our results reveal previously unobserved inhibitor binding modes and promising scaffolds for the generation of selective GMII inhibitorsKeywords
Funding Information
- Royal Society
- FP7 Ideas: European Research Council (290836, 32294)
- Biotechnology and Biological Sciences Research Council (BB/M011151/1, BB/R001162/1)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
This publication has 38 references indexed in Scilit:
- Fluorescence polarization assays in small molecule screeningExpert Opinion on Drug Discovery, 2010
- Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probesNature Biotechnology, 2009
- Functionalized pyrrolidine inhibitors of human type II α-mannosidases as anti-cancer agents: Optimizing the fit to the active siteBioorganic & Medicinal Chemistry, 2008
- Golgi α-mannosidase II cleaves two sugars sequentially in the same catalytic siteProceedings of the National Academy of Sciences, 2008
- Structural basis for cyclophellitol inhibition of a β-glucosidaseOrganic & Biomolecular Chemistry, 2006
- Man2C1, an α-mannosidase, is involved in the trimming of free oligosaccharides in the cytosolBiochemical Journal, 2006
- Characterization of a Human Core-specific Lysosomal α1,6-Mannosidase Involved in N-Glycan CatabolismJournal of Biological Chemistry, 2005
- Stage-Specific Expression of a Mouse Homologue of the Porcine 135kDa α-D-Mannosidase (MAN2B2) in Type A SpermatogoniaBiochemical and Biophysical Research Communications, 1997
- Inhibition of Human HT29 Colon Carcinoma Growth In Vitro and In Vivo by Swainsonine and Human Interferon-α2JNCI: Journal of the National Cancer Institute, 1989
- Synthesis of lysosomal α-mannosidase in normal and mannosidosis fibroblastsBiochemical and Biophysical Research Communications, 1983